Case D B, Atlas S A, Mouradian J A, Fishman R A, Sherman R L, Laragh J H
JAMA. 1980 Jul 25;244(4):346-9.
Proteinuria developed in six of 81 hypertensive patients given captopril for at least four months (protein excretion, greater than 200 mg/24 hr). Two had previously elevated protein excretion. In all patients the increased protein excretion occurred by the fourth month of treatment. It subsided in four after two to nine months, despite continued therapy. In two of the four, proteinuria cleared completely within seven months after onset, while in the other two it subsided to the range of 600 mg/24 hr. However, in the remaining two patients proteinuria persisted during captopril therapy and was associated with hypoalbuminemia and hypercholesterolemia. Renal biopsy specimens showed mild membranous nephropathy in two patients, one of whom had a remittance of proteinuria during continued captopril treatment.
81例接受卡托普利治疗至少4个月的高血压患者中有6例出现蛋白尿(蛋白质排泄量大于200mg/24小时)。其中2例之前蛋白质排泄量就已升高。所有患者的蛋白质排泄量增加均出现在治疗的第4个月。尽管继续治疗,4例患者在2至9个月后蛋白尿减轻。在这4例患者中的2例,蛋白尿在发病后7个月内完全消失,而另外2例则降至600mg/24小时的范围。然而,其余2例患者在卡托普利治疗期间蛋白尿持续存在,并伴有低白蛋白血症和高胆固醇血症。肾活检标本显示2例患者有轻度膜性肾病,其中1例在继续使用卡托普利治疗期间蛋白尿有所缓解。